The market size of Warts Therapeutics will exceed $ 2,314.60 million by 2028. Growth projections at a 3.4% CAGR between 2021 and 2028 COVID impact and global analysis by TheInsightPartners.com
The growth of the therapeutic warts market driven by the increasing prevalence of human papillomavirus (HPV) infections and recurrence of genital warts, and the development of new products; type of genital warts to dominate the market between 2021 and 2028.
New York, September 29, 2021 (GLOBE NEWSWIRE) – Warts Therapy Market: Key Insights
According to our new research study on ‘Warts Therapeutics Market to 2028 – Global Analysis and Forecast – by Type, Treatment and End User’ the Therapeutic Warts Market Size expected to reach US $ 2,314.60 million by 2028 compared to US $ 1,829.54 million in 2021; it is expected to grow at a CAGR of 3.4% during 2021-2028.
Therapeutic Warts Market: Competitive Landscape and Key Developments
Bausch Health Companies Inc .; Nielsen BioSciences, Inc .; Euro Vital Pharma GmbH, Cipla Inc .; Koninklijke UtermÃ¶hlen NV; Novan, Inc .; Scholl Welfare Society; TEVA PHARMACEUTICAL INDUSTRIES LTD; Verrica Pharmaceuticals Inc .; GlaxoSmithKline plc .; and AIM ImmunoTech Inc are among the key companies operating in the warts therapeutics market. The main players are focused on launching new products, expanding and diversifying their market presence, and acquiring new customers to exploit existing business opportunities.
Get Exclusive Sample Pages Wart Drugs Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00024332/
In April 2021, Teva Pharmaceuticals launched the first generic version of Absorica (isotretinoin) capsules for severe recalcitrant lumpy acne warts. Oral isotretinoin is a promising therapeutic choice for patients with refractory facial flat warts.
On March 21, Verrica Pharmaceuticals Inc. and Torii Pharmaceutical Co., Ltd. entered into a collaboration and license agreement to develop and commercialize product candidates, including VP-102, for a topical formulation of cantharidin for the treatment of molluscum contagiosum and common warts in Japan.
In October 2019, Novan expanded its portfolio of proprietary products for external genital warts by submitting a New Drug Pre-Investigation Request (IND) request to the United States Food and Drug Administration (FDA) for the new drug. product candidate SB207.
In 2020, North America dominated the global warts treatment market. In addition to the increasing incidence of warts and HPV infections, the increasing adoption of warts treatments in the United States and increasing research activity in these treatments is driving the market growth in the region. The United States is one of the largest and fastest growing markets for skin treatments in this region. According to the Centers for Disease Control and Prevention (CDC), about 20% of the population suffered from sexually transmitted infections (STIs) and a total of about 42.5 million people were infected with HPV in 2018 in the United States. United. In addition, before vaccination against HPV, approximately 340,000 to 360,000 women and men were affected each year by genital warts caused by HPV.
Download Sample PDF Brochure of Wart Therapy Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00024332/
Based on type, the warts therapeutics market is segmented into common warts, genital warts, flat warts, and others. The common warts segment is the largest shareholder in the market; however, the genital warts segment is expected to register the highest CAGR during the forecast period. By treatment, the warts therapeutics market is segmented into physical destruction, immunomodulation, and chemical destruction. The physical destruction market is further segmented into cryotherapy, surgical ablation, and laser treatment. Immunomodulation is sub-segmented into interferons, retinoids and zinc. The chemical destruction segment is further divided into bleomycin, cantharidin, salicylic acid and others. The physical destruction segment holds the largest share of the warts therapeutics market and is expected to register the highest CAGR of the market during the forecast period. By end user, the warts therapy market is segmented into hospitals, home care, specialty clinics, and others. The hospital segment is the largest shareholder in the market. However, the home care segment is expected to register the highest CAGR in the market during the forecast period.
The increasing prevalence of warts encourages companies in the life science industry to focus on the research and development of new drugs for the treatment of warts. There is a continuing need for new innovative therapeutic approaches for better therapeutic results. Verrica is developing VP-102 to treat molluscum contagiosum, common warts and external genital warts. VP-102 is currently under review by the FDA and may be the first product to treat molluscum contagiosum, a common and highly contagious skin disease that affects approximately 6 million people in the United States. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. Novan is developing SB206 (currently in a Phase III clinical trial) as a topical antiviral gel to treat viral skin infections, including external genital warts (EGW) caused by HPV.
Order a copy of Warts Therapeutics Size, Share, Strategic Insights and Forecast 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00024332/
Warts Therapeutics Market: Segment Overview
The physical destruction segment is expected to register the highest CAGR in the warts therapeutics market, by treatment, during the forecast period.
Browse related reports:
Peptide Therapy Market Forecast until 2027 – COVID-19 impact and global analysis by type (generic and innovative), route of administration (parenteral, oral, mucosa, pulmonary and others), synthesis technology (solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS) and hybrid technology), and application (cancer, cardiovascular disorders, metabolic disorders, respiratory disorders, pain and dermatology) and geography
Multiple Sclerosis Therapeutics Market Forecast to 2027 – COVID-19 impact and global analysis by drug class (immunosuppressants and immunomodulators), route of administration (injectable and oral) and distribution channel (hospital pharmacies, retail pharmacies and e-commerce) and geography
Postmenopausal Vaginal Atrophy Therapeutics Market Forecasts until 2028 – COVID-19 impact and global analysis by type of therapy (estrogen-based drugs, estrogen-based drugs, others); Types of products (vaginal gels, creams, tablets, rings, patches, others.); End user (hospitals, specialized clinics, others)
Therapeutic fungoid mycosis market Forecasts until 2028 – COVID-19 impact and global analysis by type (small molecules, biological products); Distribution channel (hospital pharmacies, retail pharmacies, others)
Gonorrhea Therapeutics Market Forecasts until 2028 – Covid-19 impact and global analysis – By type of infection (uncomplicated gonococcal infection, gonococcal arthritis, gonococcal meningitis and endocarditis); Treatment (Monotherapy, Dual therapy); Route of administration (Oral, Injectable); Distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, others) and geography
Gastrointestinal Stromal Tumor Therapeutics Market Forecasts until 2028 – Covid-19 impact and global analysis – by administration route (oral, parenteral); Distribution channel (hospital pharmacies, retail pharmacies, online pharmacies) and geography
Melanoma Therapeutics Market Forecasts until 2028 – COVID-19 impact and global analysis by therapy (chemotherapy, immunotherapy, targeted therapy, radiotherapy); Drugs (Opdivo, Yervoy, Mekinist + Tafinlar, Keytruda, Cotellic, Zelboraf, Imlygic, Generic drugs)
Inosine Pranobex Market Forecasts until 2028 – Covid-19 impact and global analysis – by type (tablets, syrup); Application (Immunomodulation, Antiviral Applications, Others); Application (Immunomodulation, Antiviral Applications, Others)
The Insight Partners is a one-stop-shop for industrial research in actionable intelligence. We help our clients find solutions to their research needs through our syndicated research and advisory services. We specialize in industries such as Semiconductors & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Health Informatics, Manufacturing & Construction, Medical Devices , technology, media and telecommunications, chemicals and materials.
If you have any questions about this report or would like further information, please contact us:
Contact Person: Sameer Joshi
Email: [email protected]
Phone: + 1-646-491-9876
Press release – https://www.theinsightpartners.com/pr/warts-market
Connect with us on:
RSS / Feed: https://www.theinsightpartners.com/feed/ | https://www.openpr.com/news/archive/139407/The-Insight-Partners.html